Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Microsoft Corporation    MSFT

MICROSOFT CORPORATION

(MSFT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Microsoft : Rich world could be close to normal by late 2021 if vaccine works, Bill Gates says

10/06/2020 | 12:59pm EST

* Gates: rich world could be back to normal by late 2021

* Allocation will be crucial - Gates says

* Western firms further ahead of Russia/China on Phase III

LONDON, Oct 6 (Reuters) - Rich countries could be back to close to normal by late 2021 if a COVID-19 vaccine works, is ready soon and distributed properly at scale, Microsoft founder Bill Gates said on Tuesday.

"By late next year you can have things going back pretty close to normal - that's the best case," Gates, 64, told The Wall Street Journal CEO Council.

"We still don't know whether these vaccines will succeed," Gates said. "Now the capacity will take time to ramp up. And so the allocation within the U.S., and between the U.S. and other countries will be a very top point of contention."

COVID-19 vaccines developed by Pfizer/BioNTech and AstraZeneca/Oxford University are two of the leading candidates in the race to be first to get regulatory approval in the West.

The head of the World Health Organization said on Tuesday that a vaccine against COVID-19 may be ready by the end of the year.

Gates, who made a fortune from Microsoft, has since given $36 billion to the Bill & Melinda Gates Foundation, which aims to tackle extreme poverty and poor healthcare.

Last month the foundation signed an agreement with 16 pharmaceutical companies, which Gates said committed them to scaling up manufacturing at an unprecedented speed, and making sure that approved vaccines reach broad distribution as early as possible.

VACCINE RACE

Russia has pushed ahead with its COVID-19 vaccine with mass public vaccinations alongside the main human trial, raising concerns among some observers that it was prioritising national prestige over solid science and safety.

"We're also talking with Russia and China," Gates said. "None of their vaccines are in a Phase III trial with a highly regarded regulator overseeing that trial."

Gates said that from a scientific point of view the Russian and Chinese vaccines were perfectly valid projects but the absence of a well-respected Phase III study could limit their attractiveness outside their respective countries.

"The Western companies are further ahead on doing these Phase III studies and so if those come out well and they're offered at low cost, I doubt there'll be a lot of Russian or Chinese vaccines going outside of those countries," he said.

Gates added that in the United States people should be thinking about ways to reduce hesitancy about having a COVID-19 vaccine when one is ready.

"You know, here in the U.S., we should already be thinking about which voices will help reduce the hesitancy. And so we can get a level of vaccination that really has a chance of stopping (it)."

Asked who did best at balancing the competing health and economic needs, Gates said:

"South Korea, Australia - because this is an exponential event, a little bit of intelligence early on makes a huge difference," he said. (Additional reporting by Paul Sandle; Editing by Giles Elgood)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
MICROSOFT CORPORATION -0.13% 210.11 Delayed Quote.33.41%
US DOLLAR / RUSSIAN ROUBLE (USD/RUB) 0.00% 76.0642 Delayed Quote.22.99%
All news about MICROSOFT CORPORATION
05:45aStock-Market Titans Amazon, Google and Facebook Are Also Driving Commercial R..
DJ
05:24aTech giants ask Malaysia PM to reinstate foreign ship cable waiver
RE
02:36aSUITED AVATARS AND DIGITAL OFFICES : traders and bankers embrace VR
RE
11/23Sixth Street-backed AvePoint to go public via $2 bln merger
RE
11/23Russia opens case against Google, saying it failed to delete banned content
RE
11/23Sixth Street-backed AvePoint to list via $2 billion merger with blank-check c..
RE
11/23France's Le Maire to push digital tax in first contact with Biden officials
RE
11/23Global dividends forecast to inch back from coronavirus cliff edge
RE
11/20Apple, GroupM, others ask for tough protection for data in Google lawsuit
RE
11/20Wall Street dips on fading stimulus concerns
RE
More news
Financials (USD)
Sales 2021 158 B - -
Net income 2021 51 336 M - -
Net cash 2021 76 102 M - -
P/E ratio 2021 31,1x
Yield 2021 1,04%
Capitalization 1 589 B 1 589 B -
EV / Sales 2021 9,57x
EV / Sales 2022 8,54x
Nbr of Employees 163 000
Free-Float 99,9%
Chart MICROSOFT CORPORATION
Duration : Period :
Microsoft Corporation Technical Analysis Chart | MSFT | US5949181045 | MarketScreener
Technical analysis trends MICROSOFT CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 38
Average target price 242,24 $
Last Close Price 210,11 $
Spread / Highest target 32,3%
Spread / Average Target 15,3%
Spread / Lowest Target -14,3%
EPS Revisions
Managers
NameTitle
Satya Nadella Chief Executive Officer & Non-Independent Director
Bradford L. Smith President & Chief Legal Officer
John Wendell Thompson Independent Chairman
Kirk Koenigsbauer COO & VP-Experiences & Devices Group
Amy E. Hood Chief Financial Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
MICROSOFT CORPORATION33.41%1 588 536
ZOOM VIDEO COMMUNICATIONS, INC.532.39%122 381
SEA LIMITED354.80%90 356
ATLASSIAN CORPORATION PLC75.38%52 594
DASSAULT SYSTÈMES SE4.95%47 368
SYNOPSYS INC.55.17%32 781